Evercore ISI Lifts PT on BioMarin Pharmaceutical Inc. (BMRN)
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) is one of the best healthcare stocks to buy for the long term. Evercore ISI lifted the price target on BioMarin Pharmaceutical Inc.
Biomarin Pharmaceutical Inc (BMRN)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | AQR Capital Management Cliff Asness | 7,676,541 | $429,348,929 | +15% | 0.2% |
| 2. | Viking Global Andreas Halvorsen | 7,062,077 | $398,936,730 | +17% | 1.12% |
| 3. | Citadel Investment Group Ken Griffin | 4,512,634 | $254,918,695 | +231% | 0.04% |
| 4. | Vestal Point Capital Ryan Wilder | 3,575,000 | $201,951,750 | +20% | 5.65% |
| 5. | Millennium Management Israel Englander | 3,010,308 | $170,052,299 | -1% | 0.07% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $86.75 | 3,625 | $314,468.75 | 10,905 | 2022-10-31 | Filing | |
| $78.84 | 900 | $70,955.37 | 30,740 | 2020-08-31 | Filing | |
| $78.22 | 11,900 | $930,759.69 | 29,840 | 2020-08-31 | Filing | |
| $21.76 | 161 | $3,503.36 | 100,574 | 2012-10-31 | Filing | |
| $21.76 | 548 | $11,924.48 | 15,294 | 2012-10-31 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $53.85 | 3,281 | $176,681.85 | 51,818 | 2026-05-07 | Filing | |
| $60.46 | 16,486 | $996,743.56 | 79,953 | 2026-03-11 | Filing | |
| $60.38 | 6,326 | $381,937.31 | 37,578 | 2026-02-26 | Filing | |
| $61.36 | 26,061 | $1,599,102.96 | 72,453 | 2026-02-26 | Filing | |
| $59.31 | 1,786 | $105,927.66 | 14,173 | 2025-05-20 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 19,818,301 | $1,119,535,796 | 0.02% | |
| 2. | 14,561,759 | $822,593,766 | 0.45% | |
| 3. | 14,194,005 | $801,819,344 | 0.63% | |
| 4. | 8,643,164 | $488,252,334 | 0.01% | |
| 5. | 8,298,475 | $468,780,853 | 0.02% |
News See All
10 Best Healthcare Stocks to Buy for the Long Term
On May 7, Haig Bathgate, CEO of Callanish Capital, appeared on CNCB to talk about his bullish view on the global markets amid the Iran war, and how its impact would be short-lived, especially when compared...
Is BioMarin Pharmaceutical Inc. (BMRN) One of the Top Cheap Stocks to Buy With the Biggest Upside Potential?
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) is one of the top cheap stocks to buy with the biggest upside potential. BioMarin Pharmaceutical Inc.
Top 10 Cheap Stocks to Buy with Biggest Upside Potential
He was of the view that the risk/reward for stocks is still pretty good.
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Q1 2026 Earnings Call Transcript
Operator: Good afternoon and welcome everyone to the BioMarin Pharmaceutical Inc. First Quarter 2026 Conference Call. Today's conference is being recorded.
BioMarin Pharmaceutical Inc. (BMRN) Rated Overweight at Wells Fargo Despite Voxzogo Phase 2 Study Discontinuations
TheFly reported on March 16 that Wells Fargo maintained an Overweight rating on BMRN with a $75 price target.
10 Best Stocks That Recently Issued New Debt
In this article, we will look at the best stocks that recently issued new debt and currently offer attractive upside potential for investors.
10 Quality Value Stocks Likely to Make a Comeback According to Analysts
Fidelity portfolio managers believe that predicting which stocks will lead in the coming year remains difficult, especially as market uncertainty continues to dominate investor sentiment.
10 Cheap Stocks to Buy for High Returns in 2026
On March 16, Mike Wilson from Morgan Stanley appeared on a CNBC Television interview to discuss the latest market trends and the impact of the Iran war.
BioMarin Pharmaceutical (BMRN) Receives FDA Approval for Expanded Use of PALYNZIQ in Adolescents
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) is one of the best get-rich-quick stocks to buy according to hedge funds.
Hedge Fund Resource Center